Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer
Completed
National Cancer Institute (NCI)
2004-09-01
RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) using ferumoxytol
may improve the ability to detect cancer that has spread to the lymph nodes and may help plan
effective cancer treatment.
PURPOSE: This clinical trial is studying how well MRI using ferumoxytol works in detecting
metastases to the lymph nodes in patients with primary prostate cancer or primary breast
cancer.
Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer
Completed
Massachusetts General Hospital
2004-09-01
RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) using ferumoxytol
may improve the ability to detect cancer that has spread to the lymph nodes and may help plan
effective cancer treatment.
PURPOSE: This clinical trial is studying how well MRI using ferumoxytol works in detecting
metastases to the lymph nodes in patients with primary prostate cancer or primary breast
cancer.
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
Unknown status
National Cancer Institute (NCI)
N/A
2004-02-01
This clinical trial studies magnetic resonance imaging (MRI) using a contrast imaging agent
ferumoxytol (ferumoxytol non-stoichiometric magnetite) in improving viewing tumors in
patients with high-grade brain tumors or cancer that has spread to the brain. Diagnostic
procedures, such as MRI, may help find and diagnose brain tumors and find out how far the
disease has spread. The contrast imaging agent ferumoxytol non-stoichiometric magnetite
consists of small iron particles taken by the blood stream to the brain and to the area of
the tumor. It may help visualize the blood flow going through the tumor better than the
standard substance gadolinium-based contrast agent.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
